(Q51038165)

27 March 2018

title

Functional explanation for increased atrial natriuretic peptide in systemic sclerosis. (English)

1 reference

27 March 2018

4

Waldenström A

1 reference

27 March 2018

author name string

Kazzam E

series ordinal

1

1 reference

27 March 2018

Caidahl K

series ordinal

2

1 reference

27 March 2018

Hedner T

series ordinal

3

1 reference

27 March 2018

publication date

1 November 1995

1 reference

27 March 2018

published in

Clinical Cardiology

1 reference

27 March 2018

volume

18

1 reference

27 March 2018

issue

11

1 reference

27 March 2018

page(s)

647-652

1 reference

27 March 2018

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

Ventricular atriopeptin. Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial pressure and secretion of atrial natriuretic factor into the human central circulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Plasma concentrations of alpha-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Responsiveness of atrial natriuretic factor to reduction in right atrial pressure in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial natriuretic peptide during acute treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Effect of reducing atrial pressure on atrial natriuretic factor and vasoactive hormones in congestive heart failure secondary to ischemic and nonischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Secretion of atrial natriuretic peptide from the heart in man.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Non-invasive assessment of systolic left ventricular function in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Extra-atrial expression of the gene for atrial natriuretic factor.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Simultaneous measurement of atrial natriuretic polypeptide (ANP) messenger RNA and ANP in rat heart--evidence for a preferentially increased synthesis and secretion of ANP in left atrium of spontaneously hypertensive rats (SHR)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Ventricular atrial natriuretic factor in the cardiomyopathic hamster model of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial natriuretic polypeptide (ANP) in human ventricle. Increased gene expression of ANP in dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Haemodynamic effects of atrial peptide infusion in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Atrial natriuretic peptide in man.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Non-invasive evaluation of long-term cardiac effects of captopril in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181111

7 January 2021

Identifiers

DOI

10.1002/CLC.4960181111

1 reference

27 March 2018

1 reference

27 March 2018